RLMD – relmada therapeutics, inc. (US:NASDAQ)
Stock Stats
News
1/30
06:07 am
rlmd
Medium
Relmada Therapeutics (NASDAQ:RLMD) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
1/29
07:41 am
rlmd
Low
Relmada Therapeutics (NASDAQ:RLMD) was upgraded by analysts at Zacks Research to a "hold" rating.
1/23
08:04 am
rlmd
Medium
Relmada Therapeutics (NASDAQ:RLMD) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $8.00 price target on the stock.
1/12
07:20 am
rlmd
Medium
Relmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for Two Separate Indications [Yahoo! Finance]
1/12
07:00 am
rlmd
Low
Relmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for Two Separate Indications
11/13/2025
04:01 pm
RLMD
-0.5%
MISS
8/7/2025
04:05 pm
RLMD
-2.4%
MISS
5/12/2025
04:01 pm
RLMD
-2.1%
MISS
1/23
08:04 am
Upgrades
Market Perform
Outperform
Leerink Partners
Medium
-9.1%
1/23
07:04 am
Upgrades
Market Perform
Outperform
Leerink Partners
Medium
-5.8%
12/22
07:18 am
Initiates
Buy
Jefferies
Low
0.9%
12/22
07:18 am
Initiates
Buy
Jefferies
Low
0.9%
12/21
07:08 pm
Initiates
BUY
JEFFERIES
Medium
3.9%
1/30
05:14 pm
rlmd
Medium
Form 424B5 RELMADA THERAPEUTICS,
12/16
09:31 am
rlmd
Low
Form 4 RELMADA THERAPEUTICS, For: Dec 12 Filed by: TRAVERSA SERGIO
12/16
09:30 am
rlmd
Medium
Form 4 RELMADA THERAPEUTICS, For: Dec 12 Filed by: Ence Chuck
12/16
09:30 am
rlmd
Low
Form 4 RELMADA THERAPEUTICS, For: Dec 12 Filed by: Shenouda Maged
12/16
09:29 am
rlmd
Medium
Form 4 RELMADA THERAPEUTICS, For: Dec 12 Filed by: GLASSPOOL JOHN
Show more
Top News Gainers
10/14 Relmada Therapeutics to Announce Results of Phase 2 Study of REL-1017 for Treatment Resistant Depression and Conduct Conference Call on Tuesday, October 15 134.0%
10/18 Form 8-K RELMADA THERAPEUTICS, For: Oct 17 52.4%
12/4 Relmada prices $100M equity offering [Seeking Alpha] 49.8%
3/18 Form 4 RELMADA THERAPEUTICS, For: Mar 17 Filed by: CASAMENTO CHARLES J 14.7%
3/16 Form 3 RELMADA THERAPEUTICS, For: Mar 09 Filed by: Wessel Thomas 10.6%
10/28 Form S-3/A RELMADA THERAPEUTICS, 10.5%
3/24 Relmada Therapeutics Strengthens Scientific Leadership Team with the Appointment of Judy Caron, Ph.D., as Vice President of Drug Development 10.0%
5/16 Form D RELMADA THERAPEUTICS, 8.2%
3/31 Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety 7.4%
5/15 Form 4 RELMADA THERAPEUTICS, For: May 14 Filed by: Kelly Paul Edward 7.1%
Top News Decliners
10/17 Relmada to Ring NASDAQ Stock Market Opening Bell on Friday, October 18 -18.0%
6/20 Form 8-K RELMADA THERAPEUTICS, For: Jun 14 -16.0%
10/21 Form 8-K RELMADA THERAPEUTICS, For: Oct 15 -12.3%
7/10 Form D/A RELMADA THERAPEUTICS, -10.5%
1/31 Form DEF 14A RELMADA THERAPEUTICS, For: Mar 06 -9.7%
3/9 Form 8-K RELMADA THERAPEUTICS, For: Mar 06 -8.7%
3/9 Relmada Therapeutics Appoints CNS Specialist Thomas C. Wessel, M.D., Ph.D., as Executive Vice President, Head of Research and Development -8.6%
10/24 Form EFFECT RELMADA THERAPEUTICS, -7.1%
5/1 Relmada Therapeutics Inc (OTCMKTS: RLMD) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -6.0%
4/21 Relmada Therapeutics Inc (OTCMKTS: RLMD) is now covered by analysts at Goldman Sachs Group Inc. They set a "buy" rating on the stock. -6.0%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3